Search

Author/Creator Mito, Remi

1. CD163‐positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma. Issue 10 (7th July 2021)

Authors:
Matsubara, Eri; Komohara, Yoshihiro; Shinchi, Yusuke; Mito, Remi; Fujiwara, Yukio; Ikeda, Koei; Shima, Toshiyuki; Shimoda, Masayuki; Kanai, Yae; Sakagami, Takuro; Suzuki, Makoto
Journal:
Pathology international
Issue:
Volume 71:Issue 10(2021)
Page Start:
666
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Classification of PD‐L1 expression in various cancers and macrophages based on immunohistocytological analysis. Issue 9 (15th June 2022)

Authors:
Saito, Yoichi; Fujiwara, Yukio; Shinchi, Yusuke; Mito, Remi; Miura, Yuji; Yamaguchi, Tomoya; Ikeda, Koei; Urakami, Shinji; Nakashima, Yuta; Sakagami, Takuro; Suzuki, Makoto; Tabata, Yasuhiko; Komohara, Yoshihiro
Journal:
Cancer science
Issue:
Volume 113:Issue 9(2022)
Page Start:
3255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinical impact of TROP2 in non‐small lung cancers and its correlation with abnormal p53 nuclear accumulation. Issue 5 (10th February 2020)

Authors:
Mito, Remi; Matsubara, Eri; Komohara, Yoshihiro; Shinchi, Yusuke; Sato, Kensaku; Yoshii, Daiki; Ohnishi, Koji; Fujiwara, Yukio; Tomita, Yusuke; Ikeda, Koei; Sakagami, Takuro; Suzuki, Makoto
Journal:
Pathology international
Issue:
Volume 70:Issue 5(2020)
Page Start:
287
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗